X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (5) 5
female (5) 5
humans (5) 5
index medicus (5) 5
male (5) 5
abridged index medicus (4) 4
chemotherapy (4) 4
lung neoplasms - mortality (4) 4
middle aged (4) 4
carcinoma, non-small-cell lung - mortality (3) 3
internal medicine (3) 3
lung neoplasms - drug therapy (3) 3
medicine, general & internal (3) 3
adolescent (2) 2
adult (2) 2
aged, 80 and over (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
cancer therapies (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
clinical trials (2) 2
combination (2) 2
comorbidity (2) 2
drug administration schedule (2) 2
lung cancer (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - pathology (2) 2
medical prognosis (2) 2
radiation therapy (2) 2
survival (2) 2
therapy (2) 2
1st-line therapy (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adults (1) 1
age (1) 1
angiogenesis inhibitors (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
article (1) 1
bevacizumab - administration & dosage (1) 1
bevacizumab - adverse effects (1) 1
biomarkers (1) 1
blockade (1) 1
carboplatin - administration & dosage (1) 1
carboplatin - adverse effects (1) 1
carcinoma, non-small-cell lung (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
carcinoma, squamous cell (1) 1
carcinoma, squamous cell - drug therapy (1) 1
carcinoma, squamous cell - mortality (1) 1
care and treatment (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
class i phosphatidylinositol 3-kinases (1) 1
classification (1) 1
clinical activity (1) 1
clinical outcomes (1) 1
clinical-practice (1) 1
confidence (1) 1
consulting services (1) 1
control of breathing (1) 1
coordination (1) 1
creatinine - blood (1) 1
critical care medicine (1) 1
crizotinib (1) 1
deglutition - physiology (1) 1
deoxycytidine (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
disability evaluation (1) 1
disease progression (1) 1
disease-free survival (1) 1
disorders (1) 1
docetaxel (1) 1
drug dosages (1) 1
duchenne muscular-dystrophy (1) 1
dysphagia (1) 1
electromyography (1) 1
electrophysiological evaluation (1) 1
endothelial growth factors (1) 1
endothelial growth-factor (1) 1
endothelium (1) 1
epidermal growth factor (1) 1
europe (1) 1
fluorouracil (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 257 - 265
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1079 - 1088
Summary Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but... 
Internal Medicine | GERIATRIC-ONCOLOGY | SURVIVAL | POPULATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | INTERNATIONAL-SOCIETY | OLDER | QUALITY-OF-LIFE | COMBINATION | AGE | COMORBIDITY | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Carboplatin - adverse effects | Carcinoma, Squamous Cell - mortality | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Paclitaxel - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Clinical trials | Chemotherapy | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus | Adenocarcinoma | Vinblastine | Carcinoma, Non-Small-Cell Lung | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Lung Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Deoxycytidine | Paclitaxel | Carboplatin | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.